Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuichi Ando

Showing results (41-50 of 241) with videos related to

Pageof 25
Sort By:
International Dental Journal|May 9, 2021
Evaluation of occlusal status of Japanese adults based on functional tooth unitsTakashi Zaitsu, Mari Ohnuki, Yuichi Ando, et al.
[Nihon Koshu Eisei Zasshi] Japanese Journal of Public Health|June 5, 2020
[Recent trends and challenges for older adults at community sport clubs in Japan: Analysis of FY 2016 Survey Results on Comprehensive Community Sports Clubs]Yuichi Ando, Hiroki Ueshima, Taeko Watanabe, et al.
Current Opinion in Molecular Therapeutics|July 5, 2007
UGT1AI*6 and UGT1A1*27 for individualized irinotecan chemotherapyYuichi Ando, Ken-Ichi Fujita, Yasutsuna Sasaki, et al.
Surgery Today|January 28, 2005
Effect of imatinib (STI571) on metastatic gastrointestinal stromal tumors: report of a caseYuichi Ando, Takuya Tsunoda, Yoshifumi Beck, et al.
BMJ Open|September 20, 2022
Trends in dental visits during the state of emergency for COVID-19 in Japan: a retrospective observational studyAsuka Takeda, Jun Tomio, Hideki Fukuda, et al.
Scientific Reports|November 19, 2025
Dietary and oral factors associated with eating slowly and chewing well: a National web-based studyMidori Ishikawa, Masanori Iwasaki, Rumi Tano, et al.
Journal of Clinical Periodontology|October 2, 2002
Risk factors for periodontal disease progression among elderly peopleHiroshi Ogawa, Akihiro Yoshihara, Toshinobu Hirotomi, et al.
Plos One|August 11, 2025
Correction: Effects of KRAS, STK11, KEAP1, and TP53 mutations on the clinical outcomes of immune checkpoint inhibitors among patients with lung adenocarcinomaYao Liang, Osamu Maeda, Chiaki Kondo, et al.
International Cancer Conference Journal|July 4, 2024
Long-term response to MEK inhibitor monotherapy in a patient with papillary thyroid carcinoma harboring <i>BRAF</i> <sup>V600E</sup> mutationYuko Takano, Tomoya Shimokata, Hiroshi Urakawa, et al.
Cancer Causes & Control : CCC|September 30, 2016
Should low-income countries invest in breast cancer screening?Bishal Gyawali, Tomoya Shimokata, Kazunori Honda, et al.
Pageof 25

Showing results (41-50 of 241) with videos related to

Sort By:
Pageof 25
International Dental Journal|May 9, 2021
Evaluation of occlusal status of Japanese adults based on functional tooth unitsTakashi Zaitsu, Mari Ohnuki, Yuichi Ando, et al.
[Nihon Koshu Eisei Zasshi] Japanese Journal of Public Health|June 5, 2020
[Recent trends and challenges for older adults at community sport clubs in Japan: Analysis of FY 2016 Survey Results on Comprehensive Community Sports Clubs]Yuichi Ando, Hiroki Ueshima, Taeko Watanabe, et al.
Current Opinion in Molecular Therapeutics|July 5, 2007
UGT1AI*6 and UGT1A1*27 for individualized irinotecan chemotherapyYuichi Ando, Ken-Ichi Fujita, Yasutsuna Sasaki, et al.
Surgery Today|January 28, 2005
Effect of imatinib (STI571) on metastatic gastrointestinal stromal tumors: report of a caseYuichi Ando, Takuya Tsunoda, Yoshifumi Beck, et al.
BMJ Open|September 20, 2022
Trends in dental visits during the state of emergency for COVID-19 in Japan: a retrospective observational studyAsuka Takeda, Jun Tomio, Hideki Fukuda, et al.
Scientific Reports|November 19, 2025
Dietary and oral factors associated with eating slowly and chewing well: a National web-based studyMidori Ishikawa, Masanori Iwasaki, Rumi Tano, et al.
Journal of Clinical Periodontology|October 2, 2002
Risk factors for periodontal disease progression among elderly peopleHiroshi Ogawa, Akihiro Yoshihara, Toshinobu Hirotomi, et al.
Plos One|August 11, 2025
Correction: Effects of KRAS, STK11, KEAP1, and TP53 mutations on the clinical outcomes of immune checkpoint inhibitors among patients with lung adenocarcinomaYao Liang, Osamu Maeda, Chiaki Kondo, et al.
International Cancer Conference Journal|July 4, 2024
Long-term response to MEK inhibitor monotherapy in a patient with papillary thyroid carcinoma harboring <i>BRAF</i> <sup>V600E</sup> mutationYuko Takano, Tomoya Shimokata, Hiroshi Urakawa, et al.
Cancer Causes & Control : CCC|September 30, 2016
Should low-income countries invest in breast cancer screening?Bishal Gyawali, Tomoya Shimokata, Kazunori Honda, et al.
Pageof 25